[1]
“Circulating Tumour DNA for Minimal Residual Disease: Assay Sensitivity and the Decisions It Cannot Yet Support”, TMTJ, vol. 2, no. 2, pp. 110–119, Dec. 2023, doi: 10.5281/zenodo.22649122.